Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. freshman Avg
|
|
New words:
Abbott, abdomen, abroad, Absent, accrete, accreted, acquiree, Affymetrix, aim, Analyte, analytical, APBI, appeal, Applera, arbitrage, arose, ASR, avoid, awaiting, bifurcation, blockage, blocked, Bookrunner, bug, Camptosar, Cardinal, CE, Celera, Cellient, Cervista, chemistry, chemotherapy, Circuit, clarification, clone, Coagulator, COBRA, colorectal, comment, confirm, confirmatory, Congressional, CT, deconsolidated, deconsolidation, difficulty, disbursed, drawdown, duration, dye, earliest, equivocal, Estate, exhausted, explicit, fallopian, FAS, FSP, gene, genetic, genotyping, grain, greatest, GYN, herewith, Hierarchy, holiday, host, HR, HSG, hysterosalpingogram, hysteroscope, Illumina, implantable, implicit, inherited, inside, Invader, irinotecan, joined, judge, knock, legacy, lender, Lessee, lessor, literature, Luminex, lump, Madison, mentioned, necessitate, noncontrolling, nonconvertible, nonfinancial, Northern, perception, Pfizer, pregnant, prepayment, prevalent, procurement, proportionate, prorata, quantity, rank, reagent, refinanced, refinancing, refocused, relabeled, representation, rescission, reset, resignation, revaluation, rice, RNA, Royal, satisfaction, sequential, Shareto, slackening, slightly, soft, softening, Southern, straight, structurally, structure, subordinated, SVP, theHierarchy, Thermal, thousandth, Thunder, tightening, turmoil, unchanged, undertaken, unutilized, update, vitro, warehouse, Wave, Western, Wilmington, Wisconsin
Removed:
advanced, Affinity, affirmed, aiding, Answer, anticompetitive, apparent, Appellate, applying, asserting, assertion, attorney, Behring, bringing, CADfx, Certiorari, Clayton, coated, coercive, commence, configured, cycle, Dade, declaratory, Delphi, deposition, deter, digitized, dismissal, dismissed, durability, dx, Electric, Encore, enforceable, enhancing, Explorer, exploring, extending, fabrication, fan, Fargo, fill, film, Foothill, founded, Frost, Genoa, iCAD, IDN, innovation, Insight, instant, Italy, IVA, Kodak, leader, loaned, logo, lowest, Lunar, misappropriated, mobility, moved, Multimodality, negotiation, noise, Nonemployee, Oleg, opportunity, osteoporotic, package, permanently, phased, plaintiff, point, practice, predominant, preliminarily, premier, prevail, priced, printer, producing, question, radiographic, ray, reader, readily, refused, relief, repeat, restatement, reviewing, scan, scrap, SecurView, semiconductor, SenoSound, senoview, sensitive, served, serviced, shareholder, simultaneously, slight, SmartWindow, Sokolov, sophisticated, spare, strongest, subrental, subtenant, sued, suffer, suited, superiority, Supreme, takeover, targeting, Taxation, tender, TFT, threatened, treated, treble, ultrasonic, unsolicited, valid, valuable, vapor, vertebral, vigorously, violation, visit, warrant
Filing tables
Filing exhibits
- 10-K Annual report
- 10.30 Form of Amendment to First Amended & Restated Change of Control Agreements
- 10.31 Form of Senior Vice President Change of Control Agreement
- 10.46 Executive Financial Services Program
- 18.01 Letter Re Change In Accounting Principles
- 21.01 Subsidiaries of Hologic
- 23.01 Consent of Ernst & Young LLP
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 32.2 Certification of CFO Pursuant to Section 906
Related press release
HOLX similar filings
Filing view
External links
Exhibit 18.01
November 24, 2008
Board of Directors
Hologic, Inc.
35 Crosby Drive
Bedford, MA 01730
Dear Board of Directors:
Note 2 of the Notes to the Consolidated Financial Statements of Hologic, Inc. (the “Company”) included in its Annual Report on Form 10-K for the fiscal year ended September 27, 2008 describes a change regarding the date of the Company’s annual goodwill impairment assessment from the last day of the fiscal second quarter to the first day of the fiscal fourth quarter. There are no authoritative criteria for determining which date is preferable based on the particular circumstance; however, we conclude that such change is acceptable and, based on your business judgment to make this change and for the stated reasons, is preferable in your circumstances.
Very truly yours,
/s/ Ernst & Young LLP
Boston, Massachusetts